Kilitch Drugs (India) Limited
NSE:KILITCH.NS
Overview | Financials
Company Name | Kilitch Drugs (India) Limited |
Symbol | KILITCH.NS |
Currency | INR |
Price | 311.95 |
Market Cap | 5,016,873,485 |
Dividend Yield | 0% |
52-week-range | 300 - 470 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mukund Prataprai Mehta |
Website | https://www.kilitch.com |
An error occurred while fetching data.
About Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD